BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2012

Mar 1, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2012-02-29

Reporting Person: Babu Yarlagadda S (VP Drug Discovery)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-02-29	Common Stock	M	1834	—	Acquired	54572	Direct
2012-02-29	Common Stock	M	921	—	Acquired	55493	Direct
2012-02-29	Common Stock	M	6608	—	Acquired	62101	Direct
2012-02-29	Common Stock	M	31179	—	Acquired	93280	Direct
2012-02-29	Common Stock	M	13126	—	Acquired	106406	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-02-29	Emp. Stock Option (Right to Buy)	$1.18	M	1834	Disposed	2012-08-05	Common Stock (1834)	Direct
2012-02-29	Emp. Stock Option (Right to Buy)	$1.04	M	921	Disposed	2012-12-11	Common Stock (921)	Direct
2012-02-29	Emp. Stock Option (Right to Buy)	$.87	M	6608	Disposed	2013-02-03	Common Stock (6608)	Direct
2012-02-29	Emp. Stock Option (Right to Buy)	$1.20	M	31179	Disposed	2019-03-02	Common Stock (31179)	Direct
2012-02-29	Emp. Stock Option (Right to Buy)	$1.20	M	13126	Disposed	2019-03-02	Common Stock (13126)	Direct